Intuitive Surgical (Nasdaq: ISRG) is expected to report Q2 earnings around July 19. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Intuitive Surgical's revenues will grow 22.7% and EPS will grow 22.7%.

The average estimate for revenue is $522.1 million. On the bottom line, the average EPS estimate is $3.57.

Revenue details
Last quarter, Intuitive Surgical booked revenue of $495.2 million. GAAP reported sales were 28% higher than the prior-year quarter's $388.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $3.50. GAAP EPS of $3.50 for Q1 were 35% higher than the prior-year quarter's $2.59 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 71.9%, 10 basis points better than the prior-year quarter. Operating margin was 39.0%, 80 basis points better than the prior-year quarter. Net margin was 29.0%, 220 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $2.14 billion. The average EPS estimate is $14.84.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 4,100 members out of 4,309 rating the stock outperform, and 210 members rating it underperform. Among 1,202 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,157 give Intuitive Surgical a green thumbs-up, and 45 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Intuitive Surgical is hold, with an average price target of $495.70.

The healthcare investing landscape is littered with also-rans and a few major winners. Is Intuitive Surgical the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.